Please ensure Javascript is enabled for purposes of website accessibility

Cerner Corporation Underwhelms in the Fourth Quarter

By Keith Speights - Feb 7, 2018 at 10:36AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The healthcare technology company posted weak sales growth, but record bookings could mean improvement in the near future.

Cerner Corporation's (CERN) third-quarter results announced in October were just so-so. Although the healthcare technology company reported both revenue and earnings increases, the performance wasn't impressive. However, management projected a little better growth for the fourth quarter.

So when Cerner provided its fourth-quarter update after the market closed on Tuesday, investors were eager to find out if the company was able to deliver better results. However, it again underwhelmed. Here are the highlights from Cerner's fourth-quarter performance. 

Physician holding tablet with healthcare icons displaying in foreground.

Image source: Getty Images.

Cerner results: The raw numbers

Metric 

Q4 2017 

Q4 2016 

Year-Over-Year Change

Sales

$1.31 billion $1.26 billion

4.2%

Net income from continuing operations

$336.7 million $149.7 million

125%

Adjusted diluted earnings per share (EPS)

$0.58 $0.61

(5.2%)

Data source: Cerner.

What happened with Cerner this quarter?

First, the bad news. In its third-quarter update, Cerner projected fourth-quarter revenue between $1.3 billion and $1.35 billion. The company delivered, but just barely. However, Cerner's actual adjusted earnings per share in the fourth quarter fell below its guidance of $0.60 to $0.62. Even worse, adjusted EPS declined from the prior-year period.

The good news was that Cerner posted a huge increase in GAAP net income in the fourth quarter. There is a catch, though. Nearly all of the improvement stemmed from an income tax benefit of $115 million compared to an income tax expense of $66 million in the prior-year period. The fourth-quarter tax benefit included Cerner's current estimates of the impact of U.S. tax reform enacted in December 2017.

Perhaps the best news, though, was that Cerner recorded bookings in the fourth quarter of $2.329 billion. That's an all-time high, and it reflects a year-over-year increase of 62%. Bookings represent the amount of prospective revenue from contracts signed but not yet implemented. Cerner's sales backlog at the end of the fourth quarter stood at $17.55 billion, up 10% over the prior-year period.

The company reported operating cash flow of $348.9 million during the fourth quarter. The company generated free cash flow during the period totaling $185.1 million. As of Dec. 31, 2017, Cerner had a cash position of $805.8 million, including cash, cash equivalents, and short-term investments. 

What management had to say

Cerner president Zane Burke put a positive spin on the company's fourth-quarter performance. He said:

We finished the year on a mostly positive note, with record bookings and all other key metrics except for earnings in line with our expectations. Our bookings were at record levels across several key areas, including population health, Cerner ITWorksSM, and revenue cycle, and also included strong contributions from outside of the U.S. We believe the strong bookings in the fourth quarter combined with our robust pipeline and strong competitive position sets us up for solid growth in 2018 and beyond.

Looking forward

How is the current quarter shaping up? Cerner expects first-quarter 2018 revenue between $1.315 billion and $1.365 billion. That reflects roughly 7% year-over-year growth at the mid-point of the range. The company also projects first-quarter adjusted diluted EPS between $0.57 and $0.59. In the same quarter of 2017, Cerner reported adjusted diluted EPS of $0.59. 

As for full-year 2018, Cerner projects revenue between $5.45 billion and $5.65 billion. That translates to year-over-year growth of around 8% at the mid-point of the range. However, the full-year revenue guidance was a little lower than the company's preliminary outlook provided three months ago. Full-year 2018 adjusted diluted EPS is expected to come in between $2.57 and $2.73, an 11% increase from 2017.

Investors will certainly want to watch to see what changes new CEO Brent Shafer might make. Shafer took the helm on Feb. 1, 2018. He previously served as CEO of Philips North America, part of Dutch technology company Koninklijke Philips NV. Shafer helped Philips increase profitability and expand market share -- just what Cerner shareholders would love to see in the years ahead. 

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cerner Corporation Stock Quote
Cerner Corporation
CERN
Koninklijke Philips N.V. Stock Quote
Koninklijke Philips N.V.
PHG
$21.29 (-3.18%) $0.70

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
332%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.